APA

Chalasani N., Vuppalanchi R., Rinella M., Middleton M. S., Siddiqui M. S., Barritt A. S., Kolterman O., Flores O., Alonso C., Iruarrizaga-Lejarreta M., Gil-Redondo R., Sirlin C. B. & Zemel M. B. (20190916). Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. : Alimentary pharmacology & therapeutics.

Chicago

Chalasani N, Vuppalanchi R, Rinella M, Middleton M S, Siddiqui M S, Barritt A S, Kolterman O, Flores O, Alonso C, Iruarrizaga-Lejarreta M, Gil-Redondo R, Sirlin C B and Zemel M B. 20190916. Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. : Alimentary pharmacology & therapeutics.

Harvard

Chalasani N., Vuppalanchi R., Rinella M., Middleton M. S., Siddiqui M. S., Barritt A. S., Kolterman O., Flores O., Alonso C., Iruarrizaga-Lejarreta M., Gil-Redondo R., Sirlin C. B. and Zemel M. B. (20190916). Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. : Alimentary pharmacology & therapeutics.

MLA

Chalasani N, Vuppalanchi R, Rinella M, Middleton M S, Siddiqui M S, Barritt A S, Kolterman O, Flores O, Alonso C, Iruarrizaga-Lejarreta M, Gil-Redondo R, Sirlin C B and Zemel M B. Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease. : Alimentary pharmacology & therapeutics. 20190916.